Athanassios Argiris

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Suresh S. Ramalingam, Michael L. Maitland, Paul Frankel et al. · Journal of Clinical Oncology · 2009 · 270 citations

Medicine, Oncology, Pharmacology +16

CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis

Hyun-Bae Jie, Patrick J. Schuler, Steve Lee et al. · Cancer Research · 2015 · 263 citations · Full text

Life Sciences, Immunology, Oncology +17

The impact of health insurance status on the survival of patients with head and neck cancer

Joseph M.K. Kwok, Scott M. Langevin, Athanassios Argiris et al. · Cancer · 2009 · 236 citations · Full text

Medicine, Oncology, Otolaryngology +5

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples

Αthanasios Kotsakis, Malgorzata Harasymczuk, Bastian Schilling et al. · Journal of Immunological Methods · 2012 · 209 citations · Full text

Medicine, Hematology, Immunology +14

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

Athanassios Argiris, Musie Ghebremichael, Jill Gilbert et al. · Journal of Clinical Oncology · 2013 · 208 citations · Full text

Medicine, Oncology, Pharmacotherapy +13